Edition:
United States

Anatara Lifesciences Ltd (ANR.AX)

ANR.AX on Australia Stock Exchange

1.61AUD
6:06pm EST
Change (% chg)

$0.01 (+0.62%)
Prev Close
$1.60
Open
$1.60
Day's High
$1.61
Day's Low
$1.60
Volume
171,620
Avg. Vol
35,491
52-wk High
$1.61
52-wk Low
$0.72

Consensus Recommendations

Consensus Recommendation Next Earnings (approx.) Company Fiscal Year
End Month
Last Updated
Outperform -- June 21 Nov 2017

Analyst Recommendations and Revisions

1-5 Linear Scale Current 1 Month
Ago
2 Month
Ago
3 Month
Ago
(1) BUY 0 0 0 0
(2) OUTPERFORM 2 2 2 2
(3) HOLD 0 0 0 0
(4) UNDERPERFORM 0 0 0 0
(5) SELL 0 0 0 0
No Opinion 0 0 0 0
Mean Rating 2.00 2.00 2.00 2.00

Consensus Estimates Analysis

Sales and Profit Figures in Australian Dollar (AUD)
Earnings and Dividend Figures in Australian Dollar (AUD)
  # of Estimates Mean High Low 1 Year
Ago
SALES (in millions)
Year Ending Jun-17 2 1.76 2.53 1.00 --
Year Ending Jun-18 2 3.69 4.58 2.80 4.58
Year Ending Jun-19 2 7.37 9.65 5.10 9.65
Earnings (per share)
Year Ending Jun-17 2 -4.80 -4.00 -5.60 --
Year Ending Jun-18 2 0.70 1.50 -0.10 1.60
Year Ending Jun-19 2 4.35 7.70 1.00 7.80

Historical Surprises

No historical surprise data available.

Consensus Estimates Trend

Sales and Profit Figures in Australian Dollar (AUD)
Earnings and Dividend Figures in Australian Dollar (AUD)
  Current 1 Week
Ago
1 Month
Ago
2 Month
Ago
1 Year
Ago
SALES (in millions)
Year Ending Jun-17 1.76 -- -- -- --
Year Ending Jun-18 3.69 3.69 3.69 3.69 4.58
Year Ending Jun-19 7.37 7.37 7.37 7.37 9.65
Earnings (per share)
Year Ending Jun-17 -4.80 -- -- -- --
Year Ending Jun-18 0.70 0.70 0.70 0.70 1.60
Year Ending Jun-19 4.35 4.35 4.35 4.35 7.80

Estimates Revisions Summary

  Last Week Last 4 Weeks
Number Of Revisions: Up Down Up Down
Revenue
Year Ending Jun-17 -- -- -- --
Year Ending Jun-18 0 0 0 0
Year Ending Jun-19 0 0 0 0
Earnings
Year Ending Jun-17 -- -- -- --
Year Ending Jun-18 0 0 0 0
Year Ending Jun-19 0 0 0 0